Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on August 21, 2014, 01:14:43 pm
-
When FDA issues its decision this October about whether or not to approve Gilead Sciences’ hotly anticipated hepatitis C treatment—the fixed-dose combination tablet of Sovaldi (sofosbuvir) and ledipasvir—there is a chance they may recommend only eight weeks of therapy for some people.
But that's not all: Some new drugs that have yet to come out in the pipeline are even testing regimens for as brief a treatment period as four weeks!
Read more: http://www.hepmag.com/articles/short_treatments_2502_26055.shtml